Cambrex to biomanufacture for Merrimack
Life sciences firm Cambrex has agreed a contract for the production of clinical trial quantities of Merrimack Pharmaceuticals' recombinant immunomodulatory serum protein, as its experience in the downstream purification of proteins pays off.